![J. J. Kang](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
J. J. Kang
Direttore/Membro del Consiglio presso Exonics Therapeutics, Inc.
Profilo
J.
J.
Kang currently works as a Director at Exonics Therapeutics, Inc.
Posizioni attive di J. J. Kang
Società | Posizione | Inizio |
---|---|---|
Exonics Therapeutics, Inc.
![]() Exonics Therapeutics, Inc. BiotechnologyHealth Technology Exonics Therapeutics, Inc. develops therapies for neuromuscular diseases. It also develops gene editing technologies like CRISPR/Cas9 to permanently correct the majority of duchenne muscular dystrophy mutations. The company was founded by Eric N. Olson in February 2017 and is headquartered in Cambridge, MA. | Direttore/Membro del Consiglio | - |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 1 |
---|---|
Exonics Therapeutics, Inc.
![]() Exonics Therapeutics, Inc. BiotechnologyHealth Technology Exonics Therapeutics, Inc. develops therapies for neuromuscular diseases. It also develops gene editing technologies like CRISPR/Cas9 to permanently correct the majority of duchenne muscular dystrophy mutations. The company was founded by Eric N. Olson in February 2017 and is headquartered in Cambridge, MA. | Health Technology |
- Borsa valori
- Insiders
- J. J. Kang